Global circumferential strain based on cardiac magnetic resonance is associated with ventricular arrhythmias in hypertrophic cardiomyopathy
Cailing Pu1, Jingle Fei1, Yan Wu1, Chengbin He1, and Hongjie Hu1 1Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Synopsis
Myocardial strain
parameters detected by tissue tracking on cardiac magnetic resonance (CMR-TT)
were helpful for early prediction of myocardial damage in patients with
hypertrophic cardiomyopathy (HCM). Global circumferential strain (GCS) and late
gadolinium enhancement (LGE) percentage were reliable and independent
predictors for ventricular arrhythmias (VAs) in HCM. For patients who can’t
undergo the LGE scan, reduced GCS may have potential value to identify HCM
patients with the risk of VAs.
Introduction
Hypertrophic
cardiomyopathy (HCM) is prone to myocardial heterogeneity and fibrosis, which
are the substrate of ventricular arrhythmias (VAs).1 Tissue tracking by cardiac
magnetic resonance (CMR-TT) can quantitatively reflect the global and regional
left ventricular strain from different directions.2 It is uncertain whether
myocardial strain by CMR-TT is associated with VAs.
Methods
We retrospectively included 93 HCM patients (38 with
VAs and 55 without VAs) and 30 healthy cases. Routine left ventricular
function, myocardial strain parameters and percentage of late gadolinium
enhancement (%LGE) were evaluated.
Results
Global circumferential strain (GCS) and %LGE
correlated moderately (r =0.51, P <0.001). HCM patients with
VAs had worse left ventricular ejection fraction (LVEF), global radial strain
(GRS), GCS and global longitudinal strain (GLS), and increased %LGE compared to
those without VAs (P <0.01 for all). %LGE and GCS were indicators of
VAs in HCM patients in the multivariate logistic regression analysis. HCM
patients with %LGE >5.35% (AUC 0.81, 95% CI 0.70-0.91, P <0.001)
and GCS <-14.73% (AUC 0.79, 95% CI 0.70-0.89, P <0.001) on CMR
more frequently had VAs. %LGE + GCS were superior to detect HCM patients with
VAs (AUC 0.87, 95% CI 0.79-0.95, P <0.001).
Discussion
In this study, we
found that LVEF and SVI in HCM patients were significantly increased. At the
same time, their LVESVI, GRS, GCS and GLS were obviously decreased, indicating
that the changes in myocardial strain were much earlier than routine left
ventricular systolic function. This is mainly related to the pathology that
hypertrophic myocardium induced hyper-ejected status leads to normal or even
higher LVEF and SVI.3
In fact, the disordered arrangement of hypertrophic cardiomyocytes and fibers
caused sarcomeric systolic dysfunction. Myocardial strain could reflect the
systolic function more accurately as the strain was not affected by the global
movement and adjacent myocardium.2,3 Therefore, myocardial strain is already reduced at an early stage in HCM
patients. Furthermore, myocardial diastolic strain rates (GRSDr, GCSDr, GLSDr)
were much lower when compared to healthy people, while LVEDVI was almost
normal. This result further confirmed that the myocardial strain parameters
have a higher sensitivity for detecting myocardial diastolic dysfunction. In this study, %LGE in HCM patients with VAs was significantly higher than that of
patients without VAs, but there was no significant difference in present LGE
between the two groups. The results show that the extent of LGE is the risk
factor of VAs in HCM patients, not the presence or absence of LGE. It suggest that %LGE is an independent
risk factor for VAs in HCM patients, which can be used to identify whether
there is VAs in HCM patients (AUC = 0.81). However, LGE can not be
quantitatively evaluated in patients with contraindications or other reasons. In
this study, the myocardial strain parameters of HCM patients with VAs were
significantly lower than those without VAs. Logistic regression analysis showed
that reduced GCS was an independent risk factor for vas in HCM patients. uROC
curve showed that HCM patients with GCS <-14.73% (AUC 0.79, 95% CI
0.70-0.89, P
<0.001) on CMR more frequently had VAs. %LGE + GCS were superior to detect
HCM patients with VAs (AUC 0.87, 95% CI 0.79-0.95, P
<0.001). In conclusion, CMR-TT, as a new
technology, can quickly analyze the myocardial strain of HCM only based on the
cine sequence. GCS is expected to become a new parameter to evaluate whether
there is VAs in HCM patients, which may be useful for clinical diagnosis,
treatment and prognosis.
Conclusions
Decreased GCS and increased %LGE were indicators of VAs in HCM. GCS may be a good potential predictor in identifying HCM patients with VAs, especially for those who can’t undergo the LGE scan.
Acknowledgements
No acknowledgement found.
References
1. Cardim N, Galderisi M, Edvardsen T, et al. Role of
multimodality cardiac imaging in the management of patients with hypertrophic
cardiomyopathy: An expert consensus of the european association of
cardiovascular imaging endorsed by the saudi heart association. Eur Heart J
Cardiovasc Imaging. 2015;16:280.
2. Claus P, Omar AMS, Pedrizzetti G, et al. Tissue
tracking technology for assessing cardiac mechanics: Principles, normal values,
and clinical applications. JACC Cardiovasc Imaging. 2015;8:1444-1460.
3. Haland TF, Almaas VM, Hasselberg NE, et al. Strain
echocardiography is related to fibrosis and ventricular arrhythmias in
hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imging.
2016;17:613-621.